Private Equity

A new bond issue strengthens Agilyx's finances, funding a dual strategy focused on immediate earnings and long-term tech licensing in plastic recycling.

The drive-thru giant's acquisition of Holiday Supply Shop signals a major play for the walk-thru market, promising immersive stadium experiences nationwide.

With a new celebrity ad, CoreWeave is making a play for AI dominance. But can its specialized tech overcome financial risks and challenge industry giants?

Backed by a major investment from Nuveen, TurnClear launches to offer water 'Treatment-as-a-Service,' helping industries cut costs and meet regulations.

Industrial conglomerate Schouw & Co. offers a fee for bondholder consent to spin off its aquaculture giant BioMar, a move that could unlock value but alters risk.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

Viking Therapeutics' upcoming earnings call is about more than just financials. Investors are focused on key pipeline updates for its obesity and MASH drugs.

As Vinci Compass preps its full-year 2025 results, investors watch for signs of strength in Latin America's burgeoning alternative asset market.

As Churchill Capital XI's shares and warrants begin separate trading, what does this mean for investors and the hunt for Michael Klein's next big deal?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

Veteran investor Stephen Riddell partners with Gallatin Point to launch DS2 Capital, a new firm poised to navigate the complex structured credit market.

Employers are ditching fragmented vendors for unified platforms that promise to cut costs and complexity, fueling a surge in healthcare technology M&A.

In a volatile market, NASIS founder Karen Kennedy shares a crisis-forged blueprint for disciplined investing and avoiding the perils of herd mentality.

AI insurtech Klear.ai hires strategic finance leader Logan Thompson as CFO, signaling a major push for scale, discipline, and market expansion.

A new report reveals a looming crisis: rising healthcare costs will consume more than 100% of Social Security benefits for future generations of retirees.

BlackRock's integration of Preqin data into its eFront platform creates a single, AI-driven solution, bringing public market transparency to private assets.

Main Street Capital and Iron Creek Partners facilitate a buyout of BASELoad, LLC, a key player in healthcare data, signaling a strategic push into this vital sector.

Forgent Power Solutions prices its IPO at $27 a share, targeting a massive valuation fueled by intense demand from data centers and grid modernization.

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.